Quarterly report pursuant to Section 13 or 15(d)

Medical Marijuana Investment (Narrative) (Details)

v3.2.0.727
Medical Marijuana Investment (Narrative) (Details) - 3 months ended Aug. 31, 2015
USD ($)
mo
$ / shares
$ / mo
shares
Alternative Health Product 1 1,000,000
Alternative Health Product 2 500,000
Alternative Health Product 3 2.00%
Alternative Health Product 4 5.00%
Alternative Health Product 5 500,000
Alternative Health Product 6 500,000
Alternative Health Product 7 500,000
Alternative Health Product 8 | mo 24
Alternative Health Product 9 51.00%
Alternative Health Product 10 49.00%
Alternative Health Product 11 | $ $ 45,000
Alternative Health Product 12 | $ $ 55,000
Alternative Health Product 13 0
Alternative Health Product 14 51.00%
Alternative Health Product 15 0
Alternative Health Product 16 49.00%
Alternative Health Product 17 0
Alternative Health Product 18 45.00%
Alternative Health Product 19 0
Alternative Health Product 20 55.00%
Alternative Health Product 21 0
Alternative Health Product 22 51.00%
Alternative Health Product 23 0
Alternative Health Product 24 49.00%
Alternative Health Product 25 0
Alternative Health Product 26 51.00%
Alternative Health Product 27 0
Alternative Health Product 28 49.00%
Alternative Health Product 29 51.00%
Alternative Health Product 30 51.00%
Alternative Health Product 31 51.00%
Alternative Health Product 32 | $ $ 16,287
Alternative Health Product 33 | $ 7,662
Alternative Health Product 34 | $ $ 45,000
Alternative Health Product 35 500,000
Alternative Health Product 36 1,475,714
Alternative Health Product 37 91,662
Alternative Health Product 38 | $ / shares $ 0.30
Alternative Health Product 39 | mo 6
Alternative Health Product 40 | $ / mo 7,562